Demetrix

Demetrix

Demetrix is a biotechnology company that uses genes found in natural medicines and introduces them to domesticated microbes, for example, the synthetic production of certain chemicals. Demetrix was founded by Dr Haseltine and Jay Keasling.

Dr. Haseltine is the CEO of Demetrix and was previously professor and founder of two departments at Harvard Medical School, one on HIV/AIDS and one on cancer biology. Dr. Haseltine led Human Genome Sciences, one of the first companies to apply genetics to treat disease, and founded several other biotechnology companies. Dr. Haseltine leads the Haseltine Foundation for Science and the Arts, and ACCESS Health International, both non-profits in health and the humanities.

Demetrix is named after Demeter, the greek goddess of the harvest.

Timeline

July 2019

Demetrix raises a $50,000,000 series A round from Horizons Ventures and Tuatara Capital.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Jonathan Shieber
July 11, 2019
TechCrunch
Jeff Ubersax knows yeast. The chief executive officer of Demetrix studied yeast genetics and biochemistry in school and was an early employee at Amyris Biotechnologies, a technology company that was using fermentation to make biofuels back in the early days of the first clean technology boom back in 2008. Now, the same technology that Ubersax [...]
Jonathan Shieber
July 11, 2019
TechCrunch
With skyrocketing demand for consumer products and renewed research into its medicinal value, cannabis is having a moment. The quasi-legalization of marijuana created a gold rush for the industry, and startups like Demetrix are reaping the benefits. The company, founded by the famed U.C. Berkeley researcher Jay Keasling and helmed by former Amyris executive Jeff [...]

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.